StockData
LENSAR, Inc. logo

LENSAR, Inc. (LNSR) stock

LNSRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/3026% below fair value
$4.46−0.18 (-3.88%)

Close on Nov 20, 2026Market cap $54.80MP/E –Yield –

Lensar revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Lensar's revenue for the twelve months ending Jun 30, 2026 was $60.26M, up 3.3% year over year. For fiscal 2025 it was $58.44M, up 9.2% from the year before. The highest annual figure on record is $58.44M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$58.44M+9.2%
FY2024Dec 31, 2024$53.49M+26.9%
FY2023Dec 31, 2023$42.16M+19.2%
FY2022Dec 31, 2022$35.36M+2.6%
FY2021Dec 31, 2021$34.46M+30.6%
FY2020Dec 31, 2020$26.38M-13.6%
FY2019Dec 31, 2019$30.53M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$16.50M+18.4%
Q1 FY2026Mar 31, 2026$13.43M-5.2%
Q4 FY2025Dec 31, 2025$16.03M-4.2%
Q3 FY2025Sep 30, 2025$14.32M+5.7%
Q2 FY2025Jun 30, 2025$13.94M+10.3%
Q1 FY2025Mar 31, 2025$14.16M+33.7%
Q4 FY2024Dec 31, 2024$16.73M+38.2%
Q3 FY2024Sep 30, 2024$13.54M+38.2%
Q2 FY2024Jun 30, 2024$12.64M+5.2%
Q1 FY2024Mar 31, 2024$10.59M+28.3%
Q4 FY2023Dec 31, 2023$12.11M+18.3%
Q3 FY2023Sep 30, 2023$9.80M+26.4%
Q2 FY2023Jun 30, 2023$12.01M+49.4%
Q1 FY2023Mar 31, 2023$8.25M-11.6%
Q4 FY2022Dec 31, 2022$10.23M-8.8%
Q3 FY2022Sep 30, 2022$7.75M-6.3%
Q2 FY2022Jun 30, 2022$8.04M+1.5%
Q1 FY2022Mar 31, 2022$9.34M+32.6%
Q4 FY2021Dec 31, 2021$11.22M+35.5%
Q3 FY2021Sep 30, 2021$8.27M+15.8%
Q2 FY2021Jun 30, 2021$7.92M+57.0%
Q1 FY2021Mar 31, 2021$7.04M+19.3%
Q4 FY2020Dec 31, 2020$8.28M-2.1%
Q3 FY2020Sep 30, 2020$7.15M-11.4%
Q2 FY2020Jun 30, 2020$5.05M–
Q1 FY2020Mar 31, 2020$5.91M–
Q4 FY2019Dec 31, 2019$8.46M–
Q3 FY2019Sep 30, 2019$8.07M–

More Lensar figures

See a number that looks wrong?